Unknown OBSERVATIONAL NCT04928014

Validation of a Tear-based Screening Assay for Breast Cancer

Validation of a Tear-based Screening Assay for Breast Cancer as a Supplemental Tool to Screening Mammograms

Sponsor: Namida Lab

Conditions Breast Cancer Breast Cancer Female Health Care Acceptability Health Care Utilization Health Knowledge, Attitudes, Practice Health Personnel Attitude Healthy

Interventions Schirmer Strip

Updated 7 times since 2021 Last updated: Jun 30, 2023 Started: Jun 1, 2021 Primary completion: Dec 31, 2023 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Breast Cancer and Breast Cancer Female, this trial is ongoing. The trial is conducted by Namida Lab and has accumulated 7 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Feb 2026 — Present [monthly]

Unknown

Status: Enrolling By Invitation → Unknown
Sep 2024 — Feb 2026 [monthly]

Enrolling By Invitation
Jul 2024 — Sep 2024 [monthly]

Enrolling By Invitation
Aug 2023 — Jul 2024 [monthly]

Enrolling By Invitation
Apr 2022 — Aug 2023 [monthly]

Enrolling By Invitation

▶ Show 2 earlier versions

Dec 2021 — Apr 2022 [monthly]

Enrolling By Invitation
Sep 2021 — Dec 2021 [monthly]

Enrolling By Invitation

First recorded

Jun 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Namida Lab

Data source: Namida Lab

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fayetteville, United States